Inpatient Admissions and Costs Associated with Persistent Use of Dalfampridine Extended-Release in Multiple Sclerosis: A Claims Database Analysis.
Guo A, Niyazov A, Macaulay D, Terasawa E, Schmerold L, Wu EQ, Krieger S.
Guo A, et al.
J Manag Care Spec Pharm. 2017 Jul;23(7):771-780. doi: 10.18553/jmcp.2017.23.7.771.
J Manag Care Spec Pharm. 2017.
PMID: 28650249
Free PMC article.
The study sponsor was involved in all stages of the study research and manuscript preparation. Guo and Niyazov were employees of Acorda Therapeutics at the time of this study and may own stock/stock options. ...Study concept and design were contributed by Guo, Niyaz …
The study sponsor was involved in all stages of the study research and manuscript preparation. Guo and Niyazov were employees of Acor …